If I am resistant to Sotorasib, what other drugs should I switch to?
When a patient develops resistance to Sotorasib (Sotorasib), doctors often need to re-evaluate treatment options and may consider switching to other treatment strategies to maintain or improve treatment effects. Here are some possible alternatives:
1.Combination treatment: Doctors may consider combining sotoracib with other anticancer drugs to enhance its effectiveness. Combination therapy can act on different cancer signaling pathways simultaneously to slow down or avoid the occurrence of drug resistance.
2.Other targeted therapies: Other targeted therapies targeting different molecular targets may be an option. These drugs may have different mechanisms of action to combat mutations in tumor cells and slow disease progression.

3.Immunotherapy: Immunotherapy is a treatment method that fights cancer by activating the patient's own immune system. Immunotherapies such as checkpoint inhibitors andCAR-Tcell therapy may become alternatives to stimulate the body's immune response against cancer cells.
4.Chemotherapy: For some cancer types, traditional chemotherapy may still be an option. Although chemotherapy may come with some side effects, it can still be an effective treatment in some cases.
5.Participate in clinical trials: Patients may also consider participating in clinical trials of new therapeutic drugs. This would not only provide patients with the opportunity for new treatments that are not yet on the market, but also help advance medical research.
The original drug of sotorasibu has not yet been launched in China, so patients cannot purchase it domestically and need to purchase sotorasibu through overseas channels. The price of the original version of sotorasibu in Hong Kong, China, with the specifications of 120mg*240 tablets, is around 8 million, and the price of the European version of the original drug with the same specifications is around 4 million, which is relatively expensive. The cheaper ones are the generic drugs marketed abroad. For example, the price of generic drugs in Laos and Bangladesh is around two to three thousand yuan. The price is relatively cheap, and the ingredients of foreign generic drugs are basically the same as the original drugs.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)